celecoxib and aceclofenac

celecoxib has been researched along with aceclofenac in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (42.86)	29.6817
2010's	2 (28.57)	24.3611
2020's	2 (28.57)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Alvarez-Soria, MA; Calvo, E; Egido, J; Hernández, M; Herrero-Beaumont, G; Largo, R; Sánchez-Pernaute, O; Santillana, J	1
Cheon, YK; Cho, YD; Han, CH; Jang, JY; Kim, BS; Kim, JH; Kim, YS; Kwon, KH; Moon, JH; Shim, CS; Song, HJ	1
Alvarez-Soria, MA; Calvo, E; Egido, J; Herrero-Beaumont, G; Largo, R; Moreno-Rubio, J; Santillana, J	1
Kang, M; Kim, B; Kim, MG; Moon, SJ; Shin, N	1
Kim, HJ; Kim, JG; Lee, S	1

Reviews

1 review(s) available for celecoxib and aceclofenac

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

4 trial(s) available for celecoxib and aceclofenac

Article	Year
Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac. Annals of the rheumatic diseases, 2006, Volume: 65, Issue:8 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blotting, Western; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Depression, Chemical; Diclofenac; Dinoprostone; Female; Gene Expression; Humans; Interleukin-1; Knee Joint; Male; Membrane Proteins; Osteoarthritis, Knee; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Synovial Membrane; Time Factors; Tumor Necrosis Factor-alpha	2006
Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis. Osteoarthritis and cartilage, 2008, Volume: 16, Issue:12 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cartilage, Articular; Celecoxib; Chondrocytes; Cyclooxygenase 2; Diclofenac; Dinoprostone; Down-Regulation; Female; Humans; Interleukin-1; Male; Nitric Oxide; Osteoarthritis, Knee; Pyrazoles; Sulfonamides; Synovial Membrane	2008
Pharmacokinetic Interactions Between Tegoprazan and Naproxen, Aceclofenac, and Celecoxib in Healthy Korean Male Subjects. Clinical therapeutics, 2022, Volume: 44, Issue:7 Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Benzene Derivatives; Celecoxib; Cross-Over Studies; Diclofenac; Humans; Imidazoles; Male; Naproxen; Republic of Korea; Tablets	2022
Efficacy of Aceclofenac and Ilaprazole Combination Therapy versus Celecoxib Monotherapy for Treating NSAID-Induced Dyspepsia in Lumbar Spinal Stenosis Patients. Medicina (Kaunas, Lithuania), 2023, Jul-14, Volume: 59, Issue:7 Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Double-Blind Method; Dyspepsia; Humans; Prospective Studies; Spinal Stenosis	2023

Other Studies

2 other study(ies) available for celecoxib and aceclofenac

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
[A case of complete regression of hepatocellular carcinoma during administration of COX-2 inhibitor]. The Korean journal of hepatology, 2006, Volume: 12, Issue:3 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Female; Humans; Lactones; Liver Neoplasms; Pyrazoles; Sulfonamides; Sulfones	2006

Article

Year

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013

[A case of complete regression of hepatocellular carcinoma during administration of COX-2 inhibitor].

The Korean journal of hepatology, 2006, Volume: 12, Issue:3

Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Female; Humans; Lactones; Liver Neoplasms; Pyrazoles; Sulfonamides; Sulfones

2006